DNA amplification was detected at chromosomal regions 17q21.1(harboring HER-2), 11q13.3 (CCND1), and 11q13 (FGF4) in four, three, and three tumors, respectively, though the amplification was not correlated with any clinicopathological feature of the gastric cancers. This evidence concerns the gene FGF4 and gastric cancer.